Skip to main content

Research Repository

Advanced Search

Ibrutinib and Rituximab versus Immunochemotherapy in previously untreated mantle cell lymphoma: a randomised open label phase II/III superiority trial

Lewis, David J; Jerkeman, Mats; Sorrell, Lexy; Wright, David; Glimelius, Ingrid; Poulsen, Christian B; Pasanen, Annika; Rawstron, Andrew; Wader, Karin F; Morley, Nick; Burton, Catherine; Davies, Andrew J; Lagerlöf, Ingemar; Dalal, Surita; De Tute, Ruth; McNamara, Chris; Crosbie, Nicola; Toldbod, Helle Erbs; Sanders, Jeanette; Allgar, Victoria; Aroori, Sree; Warner, Mark; Scully, Claire; Wainman, Brian; Christensen, Jacob Haaber; Riise, Jon; Sonnevi, Kristina; Bishton, Mark J; Eyre, Toby A; Rule, Simon

Authors

David J Lewis

Mats Jerkeman

Lexy Sorrell

David Wright

Ingrid Glimelius

Christian B Poulsen

Annika Pasanen

Andrew Rawstron

Karin F Wader

Nick Morley

Catherine Burton

Andrew J Davies

Ingemar Lagerlöf

Surita Dalal

Ruth De Tute

Chris McNamara

Nicola Crosbie

Helle Erbs Toldbod

Jeanette Sanders

Victoria Allgar

Sree Aroori

Mark Warner

Claire Scully

Brian Wainman

Jacob Haaber Christensen

Jon Riise

Kristina Sonnevi

Mark J Bishton

Toby A Eyre

Simon Rule



Citation

Lewis, D. J., Jerkeman, M., Sorrell, L., Wright, D., Glimelius, I., Poulsen, C. B., Pasanen, A., Rawstron, A., Wader, K. F., Morley, N., Burton, C., Davies, A. J., Lagerlöf, I., Dalal, S., De Tute, R., McNamara, C., Crosbie, N., Toldbod, H. E., Sanders, J., Allgar, V., …Rule, S. (in press). Ibrutinib and Rituximab versus Immunochemotherapy in previously untreated mantle cell lymphoma: a randomised open label phase II/III superiority trial. Lancet,

Journal Article Type Article
Acceptance Date Jul 8, 2025
Deposit Date Jul 10, 2025
Journal Lancet
Print ISSN 0140-6736
Electronic ISSN 1474-547X
Publisher Elsevier
Peer Reviewed Peer Reviewed
Public URL https://nottingham-repository.worktribe.com/output/51346761

This file is under embargo due to copyright reasons.




You might also like



Downloadable Citations